Thromboembolism in Nephrotic Syndrome: Is Warfarin the Best Option?

Initiation of Biologic DMARDs Associated with Increased VTE Risk
Initiation of Biologic DMARDs Associated with Increased VTE Risk
Arterial and venous thromboembolic disease are often complications associated with nephrotic syndrome (NS) but guidelines are lacking on the management of thrombosis in NS.

Objective: Hypercoagulability, resulting in thromboembolic events, can be a life-threatening complication of nephrotic syndrome (NS). Conventional anticoagulants, such as warfarin, have been the standard of care for more than 50 years; however, the availability of target-specific oral anticoagulants (TSOACs) have provided additional options for the treatment and prevention of thromboembolic events.

READ FULL ARTICLE Curated publisher From aop.sagepub.com

  • Latest News Your top articles for Thursday

  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More